GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » Pre-Tax Income

Beijing Strong Biotechnologies (SZSE:300406) Pre-Tax Income : ¥613 Mil (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Beijing Strong Biotechnologies's pretax income for the three months ended in Sep. 2024 was ¥141 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was ¥613 Mil. Beijing Strong Biotechnologies's pretax margin was 33.91%.

During the past 13 years, Beijing Strong Biotechnologies's highest Pretax Margin was 50.63%. The lowest was 16.14%. And the median was 45.31%.


Beijing Strong Biotechnologies Pre-Tax Income Historical Data

The historical data trend for Beijing Strong Biotechnologies's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies Pre-Tax Income Chart

Beijing Strong Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 381.90 136.93 536.99 449.36 593.56

Beijing Strong Biotechnologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.99 171.89 142.41 158.17 140.96

Competitive Comparison of Beijing Strong Biotechnologies's Pre-Tax Income

For the Diagnostics & Research subindustry, Beijing Strong Biotechnologies's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Strong Biotechnologies's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Beijing Strong Biotechnologies's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Beijing Strong Biotechnologies's Pre-Tax Income falls into.



Beijing Strong Biotechnologies Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Beijing Strong Biotechnologies's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=649.302+0+-46.992+5.188+-13.943
=594

Beijing Strong Biotechnologies's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=152.446+0+-12.06+1.338+-0.76599999999999
=141

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥613 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Strong Biotechnologies  (SZSE:300406) Pre-Tax Income Explanation

Beijing Strong Biotechnologies's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=140.958/415.674
=33.91%

During the past 13 years, Beijing Strong Biotechnologies's highest Pretax Margin was 50.63%. The lowest was 16.14%. And the median was 45.31%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Strong Biotechnologies Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Strong Biotechnologies Business Description

Traded in Other Exchanges
N/A
Address
No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.
Executives
Shuang He Executives
Luo Ai Ping Director
Directors, executives
Liu Wei Executives
Zhou Ming Executives
Zhuang Xian Min Directors, executives
Zhang Yi Executives
Liu Xi Directors, executives
Sun Xiao Lin Director
Yu Jian Ping Executives

Beijing Strong Biotechnologies Headlines

No Headlines